Author

Nyanda Elias Ntinginya

National Institute for Medical ResearchORCID 0000-0002-1575-4521Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

Andrew T. DeLaitschiD· 2 shared Anna MomotiD· 2 shared Anthony P. WestiD· 2 shared Arne KroidliD· 2 shared Caelan E. RadfordiD· 2 shared Christof GeldmacheriD· 2 shared Christoph KreeriD· 2 shared Colin Havenar‐DaughtoniD· 2 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Andrew T. DeLaitschORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of a broad and potent V3 glycan site bNAb targeting anN332gp120 glycan-independent epitope

Lutz Gieselmann, Andrew T. DeLaitsch, Malena Rohde, Caelan E. Radford, Johanna Worczinski, Anna Momot, Elvin Ahmadov, Judith A. Burger, Colin Havenar‐Daughton, Sharvari Deshpande, Federico Giovannoni, Davide Corti, Christoph Kreer, Meryem Seda Ercanoglu, Philipp Schommers, , Florian Klein

This paper identifies a potent, broad neutralizing antibody targeting a glycan-independent V3 epitope on HIV-1 Env, showing enhanced neutralization potency and resistance to escape mutations.

bioRxiv · Sep 5, 2025 · PreprintImmunology

Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy

Lutz Gieselmann, Andrew T. DeLaitsch, Malena Rohde, Henning Gruell, Christoph Kreer, Meryem Seda Ercanoglu, Harry B. Gristick, Philipp Schommers, Elvin Ahmadov, Caelan E. Radford, Andrea Mazzolini, Lily Zhang, Anthony P. West, Johanna Worczinski, Anna Momot, , Florian Klein

The paper identifies a new broadly neutralizing antibody, 04_A06, with high potency and breadth against HIV-1 strains, showing potential for prevention and therapy.

bioRxiv · Aug 27, 2025 · PreprintImmunology